James Charles Miller serves as Executive at Recro Pharma, Inc., where they oversee executive responsibilities. Since joining the company, James Charles Miller has executed 8 insider transactions totaling $18.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on Apr 8, 2024 involved selling 73,620 shares valued at $81.0K.
James Charles Miller currently holds 73,620 shares of Recro Pharma, Inc. (REPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James Charles Miller has been a net buyer of REPH stock. They have purchased $18.8K and sold $0 worth of shares.
James Charles Miller's most recent insider trade was on Apr 8, 2024, when they sold 73,620 shares at $1.10 per share.
Get notified when new Form 4 filings are submitted
| 153,923 |
| $1.10 |
| Discretionary |
| Aug 28, 2023 | SCTL | $15.0K | Purchase | 37,500 | $0.40 | Discretionary |
| May 17, 2023 | SCTL | $0 | Award | 73,620 | $N/A | Discretionary |
| May 18, 2022 | SCTL | $0 | Award | 87,500 | $N/A | Discretionary |
| Mar 18, 2022 | SCTL | $2.1K | Purchase | 1,000 | $2.15 | Discretionary |
| Nov 17, 2021 | REPH | $1.7K | Purchase | 1,000 | $1.69 | Discretionary |
| Apr 20, 2021 | REPH | $0 | Award | 26,923 | $N/A | Discretionary |